Engineered nanomedicine for myeloma and bone microenvironment targeting

Engineered nanomedicine for myeloma and bone microenvironment targeting

Bone is a favorable microenvironment for tumor growth and a frequent destination for metastatic cancer cells. Targeting cancers within the bone marrow remains a crucial oncologic challenge due to issues of drug availability and microenvironment-induced resistance. Herein, we engineered bone-homing p...

Full description

Bibliographic Details
Main Authors: Swami, Archana, Reagan, Michaela R., Basto, Pamela Antonia, Mishima, Yuji, Kamaly, Nazila, Glavey, Siobhan, Zhang, Sufeng, Moschetta, Michele, Seevaratnam, Dushanth, Zhang, Yong, Liu, Jinhe, Memarzadeh, Masoumeh, Manier, Salomon, Shi, Jinjun, Bertrand, Nicolas, Lu, Zhi Ning, Nagano, Kenichi, Baron, Roland, Sacco, Antonio, Roccaro, Aldo M., Farokhzad, Omid C., Ghobrial, Irene M., Wu, Jun, 1968-
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:en_US
Published: National Academy of Sciences (U.S.) 2015
Online Access:http://hdl.handle.net/1721.1/93754
https://orcid.org/0000-0002-9481-2258

Internet

http://hdl.handle.net/1721.1/93754
https://orcid.org/0000-0002-9481-2258

Similar Items